These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31165543)

  • 1. Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator.
    Adduci C; Spadoni L; Palano F; Francia P
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1373-1374. PubMed ID: 31165543
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator.
    Lillo-Castellano JM; Marina-Breysse M; Gómez-Gallanti A; Martínez-Ferrer JB; Alzueta J; Pérez-Álvarez L; Alberola A; Fernández-Lozano I; Rodríguez A; Porro R; Anguera I; Fontenla A; González-Ferrer JJ; Cañadas-Godoy V; Pérez-Castellano N; Garófalo D; Salvador-Montañés Ó; Calvo CJ; Quintanilla JG; Peinado R; Mora-Jiménez I; Pérez-Villacastín J; Rojo-Álvarez JL; Filgueiras-Rama D
    Heart; 2016 Oct; 102(20):1662-70. PubMed ID: 27296239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of specialized and automated features in implantable cardiac devices.
    Ayinde H; Lloyd M
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):271-285. PubMed ID: 31724786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the subcutaneous ICD.
    Willcox ME; Prutkin JM; Bardy GH
    Trends Cardiovasc Med; 2016 Aug; 26(6):526-35. PubMed ID: 27079889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond.
    van Dijk VF; Boersma LV
    Trends Cardiovasc Med; 2020 Aug; 30(6):378-384. PubMed ID: 31610949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troubleshooting implantable cardioverter-defibrillator sensing problems II.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):212-20. PubMed ID: 25691555
    [No Abstract]   [Full Text] [Related]  

  • 8. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 9. Troubleshooting implanted cardioverter defibrillator sensing problems I.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1237-61. PubMed ID: 25516582
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable Cardioverter-Defibrillators and Wearable Defibrillators: Guidelines and Updates.
    Mathuria N
    Tex Heart Inst J; 2020 Feb; 47(1):51-52. PubMed ID: 32148457
    [No Abstract]   [Full Text] [Related]  

  • 11. Inappropriate shock because of triple counting in a patient with a subcutaneous implantable cardioverter defibrillator corrected by initiation of dual site left ventricular pacing.
    van Gelder BM; Bracke FA; Simmers T
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):239-40. PubMed ID: 25691559
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting electrical storms by remote monitoring of implantable cardioverter-defibrillator patients using machine learning.
    Shakibfar S; Krause O; Lund-Andersen C; Aranda A; Moll J; Andersen TO; Svendsen JH; Petersen HH; Igel C
    Europace; 2019 Feb; 21(2):268-274. PubMed ID: 30508072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICD triple counting leading to a lethal inappropriate shock.
    Korantzopoulos P; Manolis G; Manolis AG
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):231-233. PubMed ID: 31778244
    [No Abstract]   [Full Text] [Related]  

  • 16. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of an Implantable Defibrillator to detect transition from sinus tachycardia to slow ventricular tachycardia with 'Onset' discrimination algorithm activated.
    Shah AD; Hoskins MH; Lloyd MS; Langberg JJ
    Europace; 2017 Oct; 19(10):1694. PubMed ID: 27733467
    [No Abstract]   [Full Text] [Related]  

  • 18. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S; Aktas M; Mutluer FO; Guler TE; Dervis E; Argan O; Celikyurt U; Agir A; Vural A
    Acta Cardiol; 2019 Jun; 74(3):246-251. PubMed ID: 30058473
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH; Van Gelder IC
    Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.